Dear New World Investor:
There are bull markets, bear markets, and now an Energizer Bunny market. The S&P 500 just kept pressing higher bit-by-bit, but I really though we needed at least a little breather. After yesterday’s Fed decision, there was a brief spike up to 1080, a new recovery high, that used up all the short-term energy. The S&P fell back to 1060 at the close, and I was glad to see it dip down to 1045 intraday today , which was
Read the rest of this entry
Amgen, Arena Pharmaceuticals, Clinical trial, Dendreon, Health, US Food and Drug Administration, Weight loss
BLOSSOM Trial Results Hit All Targets For Arena
Lorcaserin Will Be Approved By October 2010
Arena Pharmaceuticals (ARNA) issued their press release on the BLOSSOM Phase III clinical trial results early this morning, and the results were good. Basically BLOSSOM essentially matched BLOOM in every respect, including the all-important heart valve safety data. We’ll get more info from the company’s presentation at the Obesity Society meeting in Washington, DC from October 24 to 28. Arena plans to file their New Drug application in December, so the PDUFA date for an FDA decision should be in October 2010, ten months after the filing.. There probably will be
Read the rest of this entry
Anti-obesity medication, Body weight, Clinical trial, Contrave, Fen-phen, Health, lorcaserin, Qnexa, US Food and Drug Administration, Weight loss
